Extended-spectrum β-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae

Microbial Drug Resistance

Volumn 13, Issue 3, 2007, Pages 186-190

  Palasubramaniam, Selvi ^a   Subramaniam, Geetha ^a   Muniandy, Sekaran ^a   Parasakthi, Navaratnam ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; CEFOXITIN; EXTENDED SPECTRUM BETA LACTAMASE; PORIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SEQUENCE; ESCHERICHIA COLI; GENETIC ANALYSIS; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOXITIN; CEPHALOSPORIN RESISTANCE; DNA, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; HUMANS; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MALAYSIA; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID HYBRIDIZATION; PLASMIDS; POLYMERASE CHAIN REACTION; PORINS; SEQUENCE ANALYSIS, DNA;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 35448951363     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2007.726     Document Type: Article

References (20)

1. Bauernfeind, A., I. Stemplinger, R. Jungwirth, and H. Giamarellou. 1996. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:221-224.
2. Cormican, M.G., S.A. Marshall, and R.N. Jones. 1996. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the E-Test Screen. J. Clin. Microbiol. 34:1880-1884.
3. Coudron, P.E., N.D. Hanson, and M.W. Climo. 2003. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamase. J. Clin. Microbiol. 41:772-777.
4. Galleni, M., F. Lingberg, S. Normark, S. Cole, N. Honore, B. Joris, and J.M. Frere. 1988. Sequence and comparative analyses of three Enterobacter cloacae ampC β-lactamase genes and their products. Biochem. J. 250:753-760.
5. Hanson, N.D., K.S. Thomson, E.S. Moland, C.C. Sanders, G. Berthold, and R.G. Penn. 1999. Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J. Antimicrob. Chemother. 44:377-380.
6. Jacoby, G.A., and P. Han. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34:908-911.
7. Jarlier, V., M.H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactams in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
8. Kado, C.I., and S.T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
9. Lee, S.H., J.Y. Kim, G.S. Lee, S.H. Cheon, Y.J. An, S.H. Jeong, and K.J. Lee. 2002. Characterization of blaCMY-11, an AmpCtype plasmid-mediated beta-lactamase gene in a Korean clinical isolate of Escherichia coli. J. Antimicrob. Chemother. 49:269-273.
10. Matsuyama, S., K. Inokuchi, and S. Mizushima. 1984. Promoter exchange between OmpF and OmpC, genes for osmoregulated major outer membrane proteins of Escherichia coli K 12. J. Bacteriol. 158:1041-1047.
11. Mulvey, M.R., E. Bryce, D.A. Boyd, M. Ofner-Agostini, A.M. Land, A.E. Simor, and S. Paton. 2005. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49:358-365.
12. National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. NCCLS document, eleventh informational supplement. M100-S11, vol. 21, no.1.
13. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th edition. NCCLS, Villanova, PA. Approved Standard M2-A6.
14. Nikaido, H. 1989. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 33:1831-1836.
15. Nikaido, H., W. Liu, and E.Y. Rosenberg. 1990. Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob. Agents Chemother. 34:337-342.
16. Thomson, K.S. 2001. Controversies about extended-spectrum and AmpC β-lactamases. Emerg. Infect. Dis. 7:333-336.
17. Towbin, H., T. Staehelin, and G.R. Stark. 1979. Transfer of protein from gels to diazobenzyl paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc. Natl. Acad. Sci. USA 76:4350.
18. Vercauteren, E., P. Descheemaeker, M. Ieven, C.C. Sanders, and H. Goossens. 1997. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J. Clin. Micro. 35:2191-2197.
19. Wu, T.L., L.K. Siu, L.H. Su, T.L. Lauderdale, F.M. Lin, H.S. Leu, T.Y. Lin, and M. Ho. 2001. Outer membrane protein change combined with co-existing TEM-1 and SHV-1 β-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:755-761.
20. Yigit, H., A.M. Queenan, G.J. Anderson, A. Domenech-Sanchez, J.W. Biddle, C.D. Steward, S. Alberti, K. Bush, and F.C. Tenover. 2001. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.